Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Thu, 16th Sep 2021 10:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Galileo Resources PLC, up 20% at 1.32 pence, 12-month range 0.61p-2.80p. The miner, with projects in Botswana, Zambia and South Africa, says all conditions for licence sale agreement with ASX-listed Sandfire Resources Ltd have been met. Completion of deal set for September 22. The deal, first announced in January, will see Sandfire pay USD1.5 million in cash for nine Kalahari copper belt licences.

----------

Kibo Energy PLC, up 16% at 0.26 pence, 12-month range 0.16p-0.56p. The Africa- and UK-focused energy company will acquire just under a 55% stake in the proposed Billingham waste gasification and power plant in Teesside, UK. Fellow AIM listing Eqtec PLC will retain just under over a 45% stake. Kibo's initial funding contribution will amount to GBP3 million. Eqtec shares were 2.4% lower.

----------

AIM - LOSERS

----------

Clinigen Group PLC, down 9.7% at 632.14 pence, 12-month range 554.00p-891.79p. Staffordshire-based pharmaceuticals and services provider lowers its earnings before interest, tax, depreciation and amortisation growth outlook for the new financial year. It now expects Ebitda growth between 5% and 10%. Clinigen anticipates lower sales of the Erwinase cancer treatment. Double-digit growth was previously expected. In the year ended June 30, revenue rose 12% to GBP523.6 million from GBP466.7 million. Pretax profit more than doubled to GBP51.8 million from GBP23.2 million.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Sep 2021 09:53

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Read more
9 Sep 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Sep 2021 14:28

Clinigen signs UK distribution deal for Paion hospital drugs

Clinigen signs UK distribution deal for Paion hospital drugs

Read more
1 Sep 2021 14:07

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

Read more
1 Sep 2021 09:12

Allen out, Schnee in as Cliningen board chairman

(Sharecast News) - Pharmaceutical products and services company Clinigen announced on Wednesday that non-executive director and chairman-designate Elmar Schnee was becoming chairman with immediate effect.

Read more
25 Aug 2021 20:39

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

Read more
25 Aug 2021 07:34

Clinigen CFO Nick Keher steps down

(Sharecast News) - Pharmaceutical group Clinigen said on Wednesday that chief financial officer Nick Keher has stepped down with immediate effect "to pursue other business interests".

Read more
5 Aug 2021 10:45

Clinigen inks partnership agreement with Eyevance Pharmaceuticals

(Sharecast News) - Pharmaceutical firm Clinigen said on Thursday that it has inked an exclusive partnership agreement with Eyevance Pharmaceuticals, a wholly-owned subsidiary of Santen Pharmaceutical.

Read more
5 Aug 2021 10:42

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Read more
3 Aug 2021 15:29

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

Read more
21 Jul 2021 14:44

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

Read more
14 Jul 2021 13:23

Wednesday broker round-up

(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.

Read more
13 Jul 2021 10:43

Clinigen expects annual revenue rise in transitional year

Clinigen expects annual revenue rise in transitional year

Read more
13 Jul 2021 09:36

Clinigen ends year in line with expectations

(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net revenue was expected to be £455m, representing an increase of 12% on both a constant currency and organic basis.

Read more
11 Jul 2021 18:55

Sunday share tips: Clinigen, UK companies

(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.